Assessment of PD-L1 expression and tumour infiltrating lymphocytes in early-stage non-small cell lung carcinoma with artificial intelligence algorithms.

Journal: Journal of clinical pathology
Published Date: Jun 19, 2025

Abstract

AIMS: To study programmed death ligand 1 (PD-L1) expression and tumour infiltrating lymphocytes (TILs) in patients with early-stage non-small cell lung carcinoma (NSCLC) with artificial intelligence (AI) algorithms.

Authors

  • Aida Molero
    Pathology, Complejo Asistencial de Segovia, Segovia, Spain.
  • Susana Hernandez
    Pathology, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Marta Alonso
    Pathology, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Melina Peressini
    Tumor Microenvironment and Immunotherapy Research Group, Research Institute Hospital 12 de Octubre (i+12), Madrid, Spain.
  • Daniel Curto
    Pathology, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Fernando Lopez-Rios
    Pathology, Hospital Universitario 12 de Octubre, Madrid, Spain fernandolopezriosmoreno@gmail.com.
  • Esther Conde
    Pathology, Hospital Universitario 12 de Octubre, Madrid, Spain.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals